Parallel Advisors’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$160M Buy
3,977,404
+98,263
+3% +$3.67M 2.89% 5
2025
Q4
$135M Buy
3,879,141
+7,689
+0.2% +$604K 2.47% 6
2025
Q3
$322M Buy
3,871,452
+329
+0% +$23.8K 5.9% 3
2025
Q2
$284M Sell
3,871,123
-101,293
-3% -$7.34M 5.68% 3
2025
Q1
$220M Buy
3,972,416
+142,784
+4% +$8.69M 4.97% 3
2024
Q4
$193M Buy
3,829,632
+15,908
+0.4% +$834K 4.36% 4
2024
Q3
$176M Sell
3,813,724
-2,036
-0.1% -$72.3K 4.17% 4
2024
Q2
$124M Buy
3,815,760
+83
+0% +$2.27K 3.18% 5
2024
Q1
$96.1M Buy
3,815,677
+47,432
+1% +$1.12M 2.6% 5
2023
Q4
$122M Buy
3,768,245
+44,762
+1% +$1.23M 3.63% 4
2023
Q3
$101M Sell
3,723,483
-3,082
-0.1% -$89.2K 3.38% 3
2023
Q2
$82.9M Buy
3,726,565
+1,992
+0.1% +$45.8K 2.67% 4
2023
Q1
$80.7M Sell
3,724,573
-91
-0% -$2K 2.72% 4
2022
Q4
$75.6M Sell
3,724,664
-44,791
-1% -$1.12M 3.28% 5
2022
Q3
$96.6M Buy
3,769,455
+1,051,127
+39% +$28.1M 4.45% 3
2022
Q2
$64.6M Buy
2,718,328
+774,009
+40% +$16.9M 2.97% 5
2022
Q1
$47M Buy
1,944,319
+140,937
+8% +$3M 1.87% 9
2021
Q4
$35.7M Buy
1,803,382
+76,474
+4% +$1.55M 1.33% 11
2021
Q3
$34M Buy
1,726,908
+52,551
+3% +$1.1M 1.37% 10
2021
Q2
$36.8M Buy
1,674,357
+110,383
+7% +$2.46M 1.56% 11
2021
Q1
$37.2M Buy
1,563,974
+15,358
+1% +$410K 1.76% 10
2020
Q4
$40.5M Buy
1,548,616
+253,712
+20% +$5.35M 2.2% 7
2020
Q3
$22.5M Sell
1,294,904
-109,541
-8% -$1.75M 1.4% 15
2020
Q2
$23.6M Sell
1,404,445
-1,450
-0.1% -$20.4K 1.54% 12
2020
Q1
$16.7M Hold
1,405,895
1.35% 13
2019
Q4
$17M Buy
1,405,895
+128,044
+10% +$1.78M 1.28% 14
2019
Q3
$18.1M Buy
1,277,851
+1,275,251
+49,048% +$15.7M 1.55% 11
2019
Q2
$29K Buy
+2,600
New +$29K ﹤0.01% 1110

Other funds holding CORT